TMCnet News

President of Leading South Korean Biopharmaceutical Company Green Cross Holdings Joins Stemedica's Board of Directors [Global Data Point]
[April 23, 2014]

President of Leading South Korean Biopharmaceutical Company Green Cross Holdings Joins Stemedica's Board of Directors [Global Data Point]


(Global Data Point Via Acquire Media NewsEdge) Dr. Rhee's addition to Stemedica's board supports both companies' shared vision of moving stem-cell technologies from clinical trials into worldwide medical practice.

"Stemedica is honored to add the President of Green Cross Holdings to our board of directors," says Roger A. Howe, Ph.D., Executive Chairman of Stemedica. "Dr. Rhee is one of few industry leaders who has a proven track record for bringing innovative new technologies from clinical trials to mainstream medical practice. His expertise will help Stemedica set new standards for stem cell quality and affordability on a global scale." "Green Cross conducted extensive due diligence on stem cell technologies before making the investment to close Stemedica's funding round," says Dr. Byung-Geon Rhee, President of Green Cross Holdings. "The more we learned about Stemedica, the more we wanted to participate in its next phase of growth. I am happy to have the opportunity to serve as a member of Stemedica's board of directors." Dr. Rhee has more than 27 years of experience in bio industry. For the past 10 years, he has served in executive-level roles at Green Cross Corp. and now parent company Green Cross Holdings. Before joining the South Korean market leader, he founded United States-based gene-therapy company Expression Genetics, Inc. in 2002. He has also served as Samyang Corp.'s pharmaceutical business unit head and LG Chem's drug-development division head. He is currently Chairman of Korea Biotechnology Industry Organization (BIO), Co-President for two forums within the South Korea Ministry of Health and Welfare: Health Technology Forum and Infectious Disease R%7ED Forum. He is member of the National Academy of Engineering of Korea. He earned his B.Sc. and M.Sc. in chemical engineering from Seoul National University, his Ph.D. in chemical/biomedical engineering from Rice University and completed post-doctoral work at the University of Wisconsin, Madison.



(c) 2014 GlobalData Provided by Syndigate.info, an Albawaba.com company

[ Back To TMCnet.com's Homepage ]